Cognition Therapeutics Inc SEC filings CGTX
Cognition Therapeutics Inc has 303 filings in SEC EDGAR's recent list, going back to Jan 29, 2009. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| S-3 | Shelf registration | Dec 18, 2025 | — |
| 424B5 | Prospectus supplement | Aug 28, 2025 | — |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 26, 2024 | — |
| 424B5 | Prospectus supplement | Mar 13, 2024 | — |
| 424B5 | Prospectus supplement | Mar 11, 2024 | — |
| 424B4 | Prospectus | Jan 8, 2024 | — |
| S-3 | Shelf registration | Dec 29, 2023 | — |
| 424B5 | Prospectus supplement | Jun 28, 2023 | — |
| 424B5 | Prospectus supplement | Mar 27, 2023 | — |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| 424B5 | Prospectus supplement | Mar 10, 2023 | — |
| S-3 | Shelf registration | Dec 23, 2022 | — |
| 424B4 | Prospectus | Nov 14, 2022 | — |
| S-1 | Registration statement | Nov 7, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Nov 2, 2021 | — |
| 424B4 | Prospectus | Oct 12, 2021 | — |
| S-1MEF | Filing | Oct 7, 2021 | — |
| S-1/A | Amended registration statement | Oct 4, 2021 | — |
| S-1/A | Amended registration statement | Sep 10, 2021 | — |
| S-1/A | Amended registration statement | Aug 20, 2021 | — |
| S-1/A | Amended registration statement | Jul 29, 2021 | — |
| S-1 | Registration statement | Jul 19, 2021 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Purchase, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1455365
- Former names
- COGNITION THERAPUTICS INC (until Dec 28, 2010)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.